Search Results - "Hübner, G.E."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Reduction of the Infectivity of Scrapie Agent as a Model for BSE in the Manufacturing Process of Trasylol by Gölker, C.F., Whiteman, M.D., Gugel, K.H., Gilles, R., Stadler, P., Kovatch, R.M., Lister, D., Wisher, M.H., Calcagni, C., Hübner, G.E.

    Published in Biologicals (01-06-1996)
    “…The Trasylol ®manufacturing process was investigated with respect to its capacity for the inactivation/removal of infectivity causing bovine spongiform…”
    Get full text
    Journal Article
  2. 2

    Hemopoietic regeneration in murine spleen following transfusion of normal and irradiated marrow: different response of granulocyte/macrophage and erythroid precursors by von Wangenheim, K H, Cronkite, E P, Peterson, H P, Hübner, G E, Feinendegen, L E

    Published in Leukemia research (1987)
    “…To investigate cell proliferation in regenerating spleen, bone marrow of normal and gamma-irradiated donor mice (3 weeks after 5 Gy) was transfused into…”
    Get more information
    Journal Article
  3. 3

    Demand-control of proliferative activity in the hemopoietic system of lethally irradiated mice during transfusion-induced regeneration by Cronkite, E P, von Wangeheim, K H, Hübner, G E, Inoue, T, Peterson, H P, Feinendegen, L E

    Published in Leukemia research (1984)
    “…The extent of cell proliferation in the hemopoietic system after bone marrow transfusion of fatally irradiated mice depends on the regeneration of…”
    Get more information
    Journal Article
  4. 4

    Toxicity of Spleen Cell Suspensions from Heavily Irradiated Mice: Implications for CFU-S Seeding by Hübner, G. E., Cronkite, E. P., Laissue, J. A., K.-H. V. Wangenheim, Feinendegen, L. E.

    Published in Radiation research (01-11-1981)
    “…Cell suspensions were made from spleens of mice 5 hr to 6 days after irradiation. Mice were irradiated with 800 rad. One group of mice received a transfusion…”
    Get full text
    Journal Article
  5. 5

    Examination of the biological safety of a drug derived from mammalian organs by Hübner, G E, Koch, R C, Sprenger, K B, Stadler, P J, Gölker, C F

    Published in Arzneimittel-Forschung (01-06-1996)
    “…In order to assess the safety of a biological drug, a variety of factors have to be examined and then brought into an overall context considering the specific…”
    Get more information
    Journal Article